Perianal fistulizing Crohn's Disease (pCD) affects about 25% of patients with Crohn's Disease (CD). It remains a difficult entity to manage with a therapeutic ceiling of treatment success despite improving medical and surgical management. The refractory nature of the disease calls for an imminent need to better understand its immunopathogenesis and classification to better streamline our treatment options. In this article, we overview the current state of pCD management and discuss where the future of its management may lie.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573672 | PMC |
| http://dx.doi.org/10.3390/jcm12196379 | DOI Listing |
Publication Analysis
Top Keywords
crohn's disease
12
next?-the future
4
future perianal
4
perianal crohn's
4
disease
4
management
4
disease management
4
management perianal
4
perianal fistulizing
4
fistulizing crohn's
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!